BC
ATRC icon

Brinker Capital’s AtriCure ATRC Stock Holding History

Brinker Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$557K Buy
+12,401
New +$540K 0.02% 686

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Brinker Capital's ATRC Position: Q2 2020 in Review

Brinker Capital opened a new position in AtriCure (ATRC) in Q2 2020: 12,401 shares worth $557K. The stake represents 0.02% of the portfolio and ranks #686 among its holdings.

189 funds tracked by Wall St. Rank hold ATRC as of Q2 2020.

  • Brinker Capital held 12,401 shares of AtriCure worth $557K as of Q2 2020.
  • AtriCure was a new Brinker Capital position in Q2 2020.
  • AtriCure made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #686 holding.
  • 189 funds tracked by Wall St. Rank held AtriCure as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.